Neuroprotection: Exploring its potential to mitigate damage from traumatic brain injury or protect dopaminergic neurons in models of Parkinson's disease
Personally, weve had people who had to take a very, very small dose of just 50mg every other day until they worked with one of our dietitians to open up their pathways and clear toxins before they could use a traditional dose of 500mg
A phase II/III clinical trial (ADAPT-JR) of VYVGART in children and adolescents, defined as individuals between 2 and 18 years of age, with gMG is estimated to be completed within 2024 (NCT04833894)
In patients receiving cagrilintide 2.4 mg plus semaglutide, there was a mean body weight change from baseline of -17.1% compared to -9.8% with semaglutide alone
Observing for any adverse effects while undergoing treatment is vital
Investigated for effects on cell motility, cytoskeletal organization, and tissue repair endpoints in tendon, ligament, and muscle in preclinical studies